Viewing Study NCT02919332


Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2025-12-28 @ 5:45 AM
Study NCT ID: NCT02919332
Status: WITHDRAWN
Last Update Posted: 2020-07-24
First Post: 2016-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Study Overview

Official Title: Improved Visualization of Glioblastoma Using Delayed 18F-FDG PET/CT.
Status: WITHDRAWN
Status Verified Date: 2019-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: No participants were enrolled
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This clinical trial studies how well delayed fludeoxyglucose F-18 (18F-FDG) positron emission tomography (PET)/computed tomography (CT) works in improving visualization of brain tumors in patients with glioblastoma. Radiotracers such as 18F-FDG are highly taken up by tumors in the brain and are visualized using PET/CT. Increasing the interval of time between 18F-FDG administration and PET/CT scan may improve the visualization of brain tumors in patients with glioblastoma.
Detailed Description: PRIMARY OBJECTIVES:

I. To improve the visualization/delineation of glioblastoma lesions using delayed 18F-FDG PET/CT imaging.

OUTLINE:

Patients receive fludeoxyglucose F-18 intravenously (IV). Patients then undergo a standard of care PET/CT scan at 60 minutes and a second PET/CT scan at 240 minutes after injection.

Note:

Standard Uptake Value (SUV) is defined for state-of-the art PET/CT scanners as Standardized uptake values = count activity per ml within region of interest (MBq/ml)/\[injected dose (MBq)/body weight (kgx1000)\]

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
NCI-2016-01214 REGISTRY CTRP (Clinical Trial Reporting Program) View
JCCCID655 OTHER UCLA / Jonsson Comprehensive Cancer Center View
16-000600 OTHER UCLA / Jonsson Comprehensive Cancer Center View